, 16 , 1303-1314, doi: Nishizawa, S., Araki, H., Ishikawa, Y., Kitazawa, S., Hata, A., Soga, T., and Hara, T
TRIUMPH-1 Phase 3 Results Eli Lilly's TRIUMPH-1 trial highlighted the potential of Retatrutide
It functions as a major neurotransmitter, as a metabolic intermediate, and as a building block for many proteins
If you have Type 2 diabetes, cardiovascular disease, or sleep apnea alongside obesity, your provider should document those conditions prominently
Leptin resistance is perceived by the body as starvation, which causes the body to store more fat
Heres what you might realistically expect: Because retatrutide has in trials produced greater weight loss than many earlier treatments (for example, in one study adults on the higher dose lost ~24% of their starting weight in ~48 weeks) you may see a faster drop in body weight and fat mass than you experienced on tirzepatide